Genzyme Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Genzyme Corporation (Genzyme) is a biotechnology company, which develops and applies technologies in the life sciences targeting rare and special unmet medical needs. The company’s products and services focuses on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, and immune disease. Genzyme also develops products for the treatment of cardiovascular diseases, neurodegenerative diseases and other areas. The company operates through two business units namely, Rare Diseases business unit and Multiple Sclerosis business unit. Genzyme has presence across several geographies like Asia-Pacific, Europe and the Americas. The company is a subsidiary of Sanofi. Genzyme is headquartered in Massachusetts, the US.
Genzyme Corporation Key Recent Developments
Feb 27, 2015: Genzyme Recognizes International Rare Disease Day with Global Education and Fund-Raising Events; Announces Founding Partnership of Give RARE
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Genzyme Corporation - Key Facts 6
Genzyme Corporation - Key Employees 7
Genzyme Corporation - Key Employee Biographies 8
Genzyme Corporation - Major Products and Services 9
Genzyme Corporation - Pharmaceutical Pipeline Products Data 11
Genzyme Corporation, Pipeline Products by Therapy Area 11
Genzyme Corporation, Pipeline Products by Development Phase 12
Genzyme Corporation - History 14
Genzyme Corporation - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Genzyme Corporation - Key Manufacturing Facilities 29
Joint Venture 29
Section 2 – Company Analysis 30
Genzyme Corporation - Business Description 30
Genzyme Corporation - Corporate Strategy 31
Genzyme Corporation - SWOT Analysis 32
SWOT Analysis - Overview 32
Genzyme Corporation - Strengths 32
Strength - Global Reach 32
Strength - Synergy through Sanofi 32
Strength - Research and Development Activities 32
Genzyme Corporation - Weaknesses 33
Weakness - Patent Litigations 33
Genzyme Corporation - Opportunities 34
Opportunity - New Market Approvals and Launches 34
Opportunity - Promising Product Pipeline 34
Opportunity - Changing Demographics 34
Opportunity - Strategic Partnerships 34
Genzyme Corporation - Threats 35
Threat - Highly Competitive Industry 35
Threat - Lengthy Drug Approval Process 35
Threat - Emergence of Biogenerics / Biosimilars 35
Genzyme Corporation - Key Competitors 36
Section 3 – Company’s Lifesciences Financial Deals and Alliances 37
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 37
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 38
Genzyme Corporation, Recent Deals Summary 39
Section 4 – Company’s Recent Developments 40
Feb 27, 2015: Genzyme Recognizes International Rare Disease Day with Global Education and Fund-Raising Events; Announces Founding Partnership of Give RARE 40
Section 5 – Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Genzyme Corporation, Key Facts 6
Genzyme Corporation, Key Employees 7
Genzyme Corporation, Key Employee Biographies 8
Genzyme Corporation, Major Products and Services 9
Genzyme Corporation, Number of Pipeline Products by Therapy Area 11
Genzyme Corporation, Number of Pipeline Products by Development Stage 12
Genzyme Corporation, Pipeline Products By Therapy Area and Development Phase 13
Genzyme Corporation, History 14
Genzyme Corporation, Other Locations 21
Genzyme Corporation, Subsidiaries 25
Genzyme Corporation, Key Manufacturing Facilities 29
Genzyme Corporation, Joint Venture 29
Genzyme Corporation, Key Competitors 36
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 37
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 38
Genzyme Corporation, Recent Deals Summary 39
List of Figures
Genzyme Corporation, Pipeline Products by Therapy Area 11
Genzyme Corporation, Pipeline Products by Development Phase 12
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 37
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 38
